Lewes, DE -- (SBWIRE) -- 11/28/2016 -- This report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016.

Featured presentations of October 2016 include the pipeline of CD22-targeted immunotherapeutics, the profile of US biotech Asana Biosciences and the profile of anti-nectin-6 antibody-drug conjugate AGS67E from Astellas Pharma.

The October 2016 issue of our R&D and Business Tracker service about antibody-drug conjugates contains:

R&D and Technology Tracker
- Pipeline changes
- Regulatory news
- Technology validations
- Manufacturing news

Business Tracker for:
- Company updates
- Collaboration
- Licensing
- Merger & acquisitions
- Financing

Clinical Trial Tracker

Scientific Publication Tracker
- Featured ADC Profile: AGS67E
- Featured Company Profile: Asana Biosciencess
- Featured Target Pipeline: Anti-CD22 Immunotherapeutics

CD-22Targeted Immunotherapeutics include:
- Naked Antibodies & Combinations
- Radioimmunotherapeutics
- Immunotoxins
- Antibody-Drug Conjugates
- Autologous CAR T-Cells

Information about the anti-CD22 Immunotherapeutics pipeline is provided in a tabular format and fully referenced.

Methodology:
Information released during the previous month is retrieved from a variety of sources including corporate press releases and statements, quarterly company business reports, SEC filings, company presentations, company websites, interviews, webcasts, journal articles, scientific abstracts and reviews, relevant scientific meetings, clinical trial databases, and Publisher's proprietary database. Relevant information is presented in textual and tabular formats with disclosure of scientific references or by a hyperlink leading to the source of information.

Customized Update Service:
The above described information service represents our standard module. At an incremental cost, the service can be exclusively widened and customized to specific client needs, e.g. preparation of a preferred presentation format, inclusion of a watch list for tracking, executive summary etc.

For more information Visit at: http://www.marketresearchreports.com/la-merie-publishing/anti-cd22-immunotherapeutics-october-2016-rd-and-business-tracker-antibody-drug

Find all Therapeutic Reports at: http://www.marketresearchreports.com/therapeutic

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions